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Optogenetics may be the answer to a
search for temporal and spatial specificity
in neuroscience. The well-known trade-off
between temporal and spatial specificity
might be resolved with this “combina-
tion of genetic and optical methods to
achieve gain or loss of function of well-
defined events in specific cells of living
tissue” (Deisseroth, 2011). It is a tech-
nology that enables researchers to stim-
ulate cells with light, thereby allowing
for the direct control of behavior. Until
now, this technique has been applied in
animal research only but, as we argue,
it holds promise for research in humans
as well.
The idea of using light to control
cells is not a recent one. Already in
1979, Francis Crick anticipated the strug-
gle of neuroscience to target individual
cells in vivo without affecting others, and
he suggested light as a tool to achieve
that. Around that time it became clear
that certain microorganisms possess pro-
teins that respond to light. Oesterhelt
and Stoeckenius (1971) discovered bacte-
riorhodopsin, an ion-pump that can be
activated by light photons. Other mem-
bers of this family were identified soon
after, including halorhodopsin (Matsuno-
Yagi and Mukohata, 1977) and channel-
rhodopsin (Nagel et al., 2002). In 2005,
researchers at Karl Deisseroth’s laboratory
first demonstrated a single-component
optogenetic system (Boyden et al., 2005),
and in 2006 the term “optogenetics” was
born.
It is beyond the scope of this arti-
cle to provide an exhaustive discussion of
all discoveries that led to what optoge-
netics is today, or of all the impressive
and sophisticated advances to improve the
technique. Instead, we will restrict our-
selves to briefly introducing the general
concept of optogenetics and discussing its
potential for cognitive neuroscience.
THE PROCESS OF OPTOGENETICS
Strictly speaking, optogenetics involves
“experimenting with a combination
of genetic manipulation and optics”
(Kasparov, 2011). It can be used in several
animal models, including the C. elegans,
fly, zebrafish, mouse, rat, and primate
(Fenno et al., 2011). Ultimately, optoge-
netics may be used to control the behavior
of freely moving mammals by administer-
ing light. However, several steps need to
be taken to achieve this, as illustrated in
Figure 1.
First, the opsins of interest have to
be specified. Optogenetics has mostly
focussed on microbial opsins, because
these are capable of directly coupling light
to rapid ion transport (Yizhar et al., 2011a;
Han, 2012). However, since microbial
opsins serve strictly as ion flow modu-
lators, animal opsins are being used for
biochemical control (Fenno et al., 2011).
Neuronal activation can be obtained by
illuminating channelrhodopsin-2 (ChR2)
with blue light, while neuronal inhibition
results from illuminating halorhodopsin
(NpHR) with yellow light. Receptor-
mediated intracellular signaling can
be achieved by shining green light on
OptoXRs, see Figure 1A.
The next step is tomake sure that mam-
malian cells express microbial opsins, for
example by using virus carrier systems
(Figure 1B). The virus carries the opsin
gene and is injected into the cell of inter-
est. There are several types of viral vec-
tors that can be used for this purpose, the
most common being the Lenti and adeno-
associated virus (AAV).
Finally, light has to be delivered into
the brain. This can be achieved by using a
chronically implanted cannula (affixed to
the skull) to which an optical fiber can be
attached (Figure 1C). Laser light can then
be delivered via this optical fiber directly
into the brain (Zhang et al., 2010).
THE APPLICATION OF OPTOGENETICS
Many questions in cognitive neuroscience
regarding the molecular, cellular and
circuit-level underpinnings of behav-
ior still remain unresolved due to the
trade-off between temporal and spatial
specificity. Since optogenetic tools have
become available to the scientific commu-
nity, numerous studies have applied this
method successfully to answer such ques-
tions. The advantage of optogenetics over
other neuromodulation techniques is its
high-temporal specificity combined with
cellular precision. For example, although
electrical manipulation has a high tem-
poral resolution, it is unable to achieve
true inactivation or excitation of indi-
vidual neurons. Pharmacological and
genetic manipulations show the oppo-
site pattern, they can target at least certain
kinds or families of neurons but are lack-
ing temporal precision (Fenno et al.,
2011). Optogenetics can be applied to
very diverse research topics, even outside
neuroscience. Here, we will limit ourselves
to a few studies that successfully applied
optogenetic tools in areas that are relevant
for cognitive neuroscience; for a broader
picture see the special issue of Biological
Psychiatry on this topic (Deisseroth, 2012).
Optogenetics has been successfully
applied in neuromodulation research. For
example, Witten et al. (2011) used opto-
genetic tools to clarify the relationship
between dopamine (DA) neuron firing
and positive reinforcement in genetically
modified rats. They observed that opti-
cal stimulation of DA neurons in the
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FIGURE 1 | Optogenetic stimulation consists of several steps. (A) First,
light-responsive proteins called opsins need to be specified. There are two
distinct superfamilies: microbical opsins (type I) and animal opsins (type II).
Both types require retinal (a vitamin A-related organic cofactor) to convert light
into energy, and the binding of retinal renders these opsins rhodopsins (Fenno
et al., 2011). Several types of microbial opsins have been identified as suitable
for optogenetic control and each type reacts differently to light stimulation of
particular wavelengths; e.g., blue light makes channelrhodopsin-2 (ChR2)
rapidly depolarize a neuron. The opsins used for optogenetics have different
ion conductance regulation properties, acting within timeframes ranging from
milliseconds to tens of minutes (Fenno et al., 2011). Examples include ChETAs
(modified ChR2 opsins) that allow for ultrafast optogenetic control, and
step-function opsins, purposely engineered to show prolonged activity after
termination of the light stimulus (Fenno et al., 2011). As for neuronal inhibition,
certain light-activated pumps may be used, such as the Natronomonas
pharaonis Halorhodopsin (NpHR) ion pump. Here, halorhodopsins
hyperpolarize the neuron in reaction to yellow light. Finally, biochemical control
can be achieved by using type II animal opsins. Controlling G protein-coupled
receptors has now been made possible by modifying them into so-called
optoXRs (Airan et al., 2009). These proteins allow for receptor-mediated
intracellular signaling by responding to green (500 nm) light (Fenno et al.,
2011). (B) The next step is to make sure that mammalian cells express
microbial opsins. Because simply administering a protein will not work, a gene
that encodes for the opsin needs to be introduced to specific cells instead.
One possibility is to inject a (harmless) virus to carry the opsin gene into the
brain of a mammal. The major drawback of viral expression systems is that
they cannot carry large amounts of genetic material. However, the advantage
is that opsins are expressed in high levels. Another way to introduce opsins is
to use transgenic (knock-in) animals that possess the opsins from birth. This
obviously has the advantage of studying the development of a system.
However, transgenic animals show lower opsin expression levels. Other
options include the use of Cre-driver animals, Cre-dependent viruses or in
utero electroporation. It is also possible to target circuits by “projection
targeting,” where light is delivered to an axon instead of the soma, or to use
viruses that transduce along axon terminals. Combination strategies are also
possible, as the detailed overview of Fenno et al. (2011) shows. (C) Light can
be delivered straight into the brain through an optical fiber, using a chronically
implanted cannula that is affixed to the skull.
ventral tegmental area of these rats led
to vigorous intracranial self-stimulation.
Likewise, Tsai et al. (2009) demonstrated
that phasic dopaminergic activity is suf-
ficient to mediate mammalian behavioral
conditioning, by using an optogenetic
approach. They emphasize that integrat-
ing optogenetics with other approaches
(e.g., electrophysiological, behavioral and
electrochemical methods) will reveal rel-
evant interactions of DA neurons with
other neuromodulatory circuits (e.g.,
monoaminergic and opioid circuits). The
use of optogenetics further revealed oppo-
site roles of D1+ and D2+ neurons (in the
nucleus accumbens) in processing cocaine
reward (Lobo et al., 2010). In this study
the firing rate of D1+ and D2+ neurons
was selectively controlled to investigate
the resulting effects on cocaine reward. It
was found that activation of D2+ neurons
suppresses cocaine reward, while activa-
tion of D1+ neurons shows the opposite
pattern. Another example of optogenetic
neuromodulation shows how symptoms
of Parkinson’s disease can be either aggra-
vated or improved (Kravitz et al., 2010).
Kravitz et al. (2010) modulated the firing
activity of single neurons, manipulating
either direct or indirect pathways in the
basal ganglia. Another study (Bass et al.,
2010) showed how neuronal dopamine
release patterns could be evoked in the
dorsal part of the striatum in living rats.
Results like these show that the use of
optogenetics can lead to a better under-
standing of cause-effect relationships, for
example in dopamine-based disorders.
The neural underpinnings of sleep
have also been investigated with opto-
genetic methods (Adamantidis et al.,
2007; de Lecea et al., 2012). In a recent
review de Lecea et al. (2012) dis-
cuss the use of optogenetics in sleep
research as well as in studying the
interactions between neuromodulatory
systems [e.g., hypocretin (Hcrt) and locus
coeruleus/norepinephrine systems]. The
authors stress the importance of opto-
genetics for controlling neural circuits
to examine boundaries between sleep
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and wakefulness (de Lecea et al., 2012).
In line with this, researchers stimulated
Hcrt producing neurons in freely moving
mice (Adamantidis et al., 2007), which
led to an increased probability of sleep-
ing mice becoming awake (either from
slow wave sleep or rapid eye movement
sleep). Interestingly, Hcrt deficiency is
associated with the neurological disorder
narcolepsy in which sleeping patterns are
altered (Adamantidis et al., 2007), and an
optogenetic approach may provide further
insights into such disorders.
Another area that has successfully
been studied with optogenetics is depres-
sion (Lobo et al., 2012). For instance,
optogenetic stimulation of the medial
prefrontal cortex (mPFC) was found to
initiate rapid antidepressant-like responses
in mice (Covington et al., 2010). Lobo
et al. (2012) stress the importance of using
optogenetics to study depression, since it
allows for answering important questions
regarding depression, which have been left
unanswered thus far.
A recent review (Yizhar, 2012) on
neural circuitries in social functioning
revealed how optogenetics might improve
our understanding of social behavior and
psychiatric impairments, and possibly lead
to the development of novel treatment
methods. Yizhar et al. (2011b) propose
the excitation and inhibition (E/I) bal-
ance hypothesis, stating that imbalance
in the inhibition and excitation pattern
within neural circuitries is involved in
several psychiatric diseases and behav-
ioral deficits (e.g., autism, schizophrenia).
Using an optogenetic approach, it was
indeed found that elevations of cellular
E/I balance in the mPFC led to increased
high-frequency power (30–80Hz range)
and behavioral impairment (Yizhar et al.,
2011b). Optogenetics has further been
applied to cortical oscillations (synchro-
nized neural activity), that are associated
with various cognitive processes as well
as psychiatric conditions such as anxiety,
autism, and schizophrenia (Sohal, 2012).
Sohal (2012) demonstrated how a partic-
ular class of inhibitory interneurons play
a causal role in the occurrence of gamma
oscillations, which is important for the
way neurons communicate.
In addition, several studies used opto-
genetics to investigate neural circuits that
underlie fear conditioning and memory
formation (see Johansen et al., 2012, for
a review). Other work on contextual fear
memories revealed that optogenetic inhi-
bition of CA1 hippocampal neurons can
reverse contextual fear memory recall,
even weeks after training (Goshen et al.,
2011). Studies like these play an impor-
tant role in the understanding of funda-
mental cognitive processes like memory
formation, but also in anxiety disorders
and posttraumatic stress disorder, which
are characterized by disturbing, recurring
contextual memories.
Finally, a promising methodological
approach of optogenetics is the combina-
tion with functional Magnetic Resonance
Imaging (fMRI). This combination has
been termed “opto-fMRI” or “ofMRI”
(Desai et al., 2011; Deisseroth, 2012), and
has been applied to several domains (Desai
et al., 2011; Abe et al., 2012). Although
still facing some challenges (Christie et al.,
2012), the combination of fMRI with
optogenetics provides a unique possibil-
ity to observe how functional changes in
the brain are brought about as a result of
optogenetic manipulation.
CONCLUSION
In sum, optogenetics is a promising tool
for cognitive neuroscience and we believe
that it might be applied to human sub-
jects in the long run. Although the area
still faces many obstacles, the field of
optogenetics is growing rapidly and new
advances are continuously being made to
improve the technique (for a review see
Dugue et al., 2012). For instance, opto-
genetic modulation in primate neurons
has been investigated (Diester et al., 2011)
and it has already been demonstrated that
ChR2 can function within human neurons
(Weick et al., 2010). Furthermore, results
from optogenetic studies could be used
to determine more effectively the specific
region for applying Transcranial Magnetic
Stimulation or Deep Brain Stimulation
(DBS). Since in DBS all cells in a certain
region are stimulated, many side effects
have been reported (Frank et al., 2007;
Serranová et al., 2013). Optogenetic stim-
ulation would not result in such side
effects because of its spatial specificity and
could therefore potentially even replace
DBS treatment in the future (Lalumiere,
2011). In addition, approaches like opto-
fMRI might be translatable to humans
in the medium term (Bullmore, 2012).
Taken together, we believe that optoge-
netics complements other neuroscientific
methods and should be used on a wider
scale within cognitive neuroscience.
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